Objective: To use familial risk analysis to examine the association between attention-deficit hyperactivity disorder (ADHD) and nicotine dependence (ND).
Abbreviations

Clinical Implications
• Children with ADHD who have nicotine-dependent parents represent a subgroup at higher risk for the development of ND.
• These high-risk ADHD children should be targeted for early identification and preventive efforts aimed at reducing their risk for ND.
Limitations
• ND was defined by smoking and not by other forms of tobacco use.
• Because the sample group was referred and overwhelmingly Caucasian, more work is needed to evaluate whether these results can be generalized to community samples and other racial or ethnic groups.
A disproportionately large number of people with ADHD smoke cigarettes, with an earlier initiation, a greater risk of progression to regular smoking, and a greater difficulty quitting smoking, compared with control subjects without ADHD. [1] [2] [3] [4] A recent meta-analysis 5 examined the association of childhood ADHD and smoking in 27 studies involving 4100 probands with ADHD and 6800 control subjects, with an average age at follow-up of 19 years. In this report, Lee et al 5 described a 2-to 3-fold increased risk of nicotine use (OR 2.08, 95% CI 1.66 to 2.60, P < 0.001) and ND (OR = 2.82, 95% CI 2.41 to 3.29, P < 0.001) in children with ADHD, compared with children without ADHD. Consistent with these findings, the NCS Replication found that, among all psychiatric disorders, childhood externalizing disorders (principally ADHD) were most strongly predictive of nicotine use and dependence in young adulthood. 6 Despite the high level of clinical and public health concern regarding smoking in youth with ADHD, uncertainties remain as to the nature of these associations.
The reasons for the increased risk for smoking in people with ADHD remain unclear and could certainly be the consequence of self-medication. However, because genes influence susceptibility for both ADHD 7,8 and smoking, 9, 10 the family study approach can provide insight into the nature of the association between the 2 disorders. Familial risk analyses can test specific hypotheses about the familial relation between ADHD and ND based on models proposed by Pauls et al, 11 which examine whether ADHD and ND are etiologically independent, represent a distinct familial subtype, or are both influenced by common familial etiologic factors. A better understanding of the nature of the association between ADHD and smoking has important clinical and public health implications. If the risk for smoking in children with ADHD is familial, it could suggest that genes determine this risk. Given that the average age at onset of ADHD symptoms is in the preschool years 12, 13 and the average age at onset of smoking is in early adolescence, 14, 15 there is a potential 10-year window to target smoking prevention programs to children with ADHD at high risk for the development of ND. Considering that ADHD afflicts 10% of children in the United States, 16 that the disorder is highly persistent, that the risk for smoking is significantly increased in people with ADHD, and that smoking is associated with high levels of morbidity and mortality, efforts aimed at further understanding risk factors for smoking are of high clinical and public health relevance.
Our study mainly aimed to use familial risk analysis to examine the nature of the association between ADHD and ND. To this end, we used data from a large, longitudinal sample of boys and girls with and without ADHD ascertained from pediatric and psychiatric referral sources and their first-degree relatives. 17, 18 Because probands and their siblings were followed for 10 years into young adult years, all subjects had entered the age of risk for the development of ND. We focused our analyses on ND as it represents the most serious manifestation of cigarette smoking. Familial risk analyses were used to test 3 competing hypotheses: 1. ADHD and ND are etiologically independent. 2. ADHD and ND represents a distinct familial subtype. 3. ADHD and ND share common familial etiologic factors. To our knowledge, this is the first familial risk analysis examining the association between ADHD and ND.
Method
Subjects
As previously reported, 17,19-21 subjects were derived from 2 similarly designed longitudinal case-control family studies of ADHD. These studies recruited boy and girl probands aged 6 to 18 years with (140 boys and 140 girls) and without (120 boys and 122 girls) ADHD ascertained from pediatric and psychiatric clinics and their first-degree relatives (ADHD families: 280 mothers, 274 fathers, and 317 siblings; control families: 242 mothers, 235 fathers, and 260 siblings). Potential subjects were excluded if they had been adopted or if their nuclear family was not available for study. We also excluded potential subjects if they had major sensorimotor handicaps (for example, paralysis, deafness, and blindness), psychosis, autism, inadequate command of the English language, or a Full Scale IQ of less than 80. Two independent sources provided the index children. The psychiatric referral source was a major academic medical centre, from where we selected subjects with ADHD based on consecutive referrals to its pediatric psychopharmacology clinic. We selected control subjects (without ADHD) from outpatients referred for routine physical examinations to its pediatric medical clinics. The pediatric referral source was a major health maintenance organization, from where we selected subjects with ADHD among consecutively ascertained pediatric clinic outpatients, identified from their computerized records as having ADHD. Again, we selected control subjects from outpatients referred for routine physical examinations to its pediatric medical clinics, identified from their computerized records as not having ADHD. We have previously demonstrated no clinically or statistically significant differences between subjects with ADHD ascertained from these 2 referral sources on measures of psychopathology, cognitive performance, or psychosocial functioning. 22 We used a 3-stage ascertainment procedure to select subjects because screening can decrease false positives and improve the accuracy of psychiatric diagnoses. 23, 24 For subjects with ADHD, the first stage was their referral, resulting in a clinical diagnosis of ADHD by a child psychiatrist or pediatrician. Because many different clinicians using different clinical standards made these diagnoses, we included a second, systematic stage that confirmed the diagnosis of ADHD by screening all children positive at the first stage using a telephone questionnaire with their mother. Eligible subject children meeting study entry criteria were recruited for the study and received a diagnostic assessment with a structured interview as the third stage. Only patients who received a positive diagnosis at all 3 stages were included in the final analysis. We also screened potential control subjects without ADHD in 3 stages. First, as described above, we ascertained these control subjects from referrals. In stage 2, the control mothers responded to the DSM-III-R ADHD telephone questionnaire. We recruited eligible control subjects meeting study entry criteria and administered a diagnostic assessment with a structured interview as stage 3. Only subjects classified as not having ADHD at all 3 stages were included in the control group. Using repeated measurements to determine patient and control status, and only accepting subjects with consistent results, provided additional assurance that we had not incorrectly specified the baseline ascertainment diagnosis of our subjects. Parents were assessed at baseline only (because they had passed the age of risk for most psychopathology), whereas probands and siblings were assessed at multiple follow-up times (boys' study: 1-year, 4-year, and 10-year follow-up; girls' study: 5-year and 11-year follow-up). As we have done in our many publications derived from our family studies of youth with ADHD, 16, [18] [19] [20] we based diagnoses of subjects aged under 12 years on mothers' reports. Subjects between the ages of 12 and 17 years received both indirect and direct interviews, and we considered a diagnosis as positive if either of the interviewees endorsed the disorder. Subjects aged 18 years and over received direct interviews. We did not directly interview children under age 12 years because of their limited capacity to provide accurately detailed lifetime psychiatric diagnostic information. Parents provided consent for offspring under the age of 18 years. Children and adolescents provided written assent to participate. The human research committee at Massachusetts General Hospital approved this study. We measured SES using the 5-point Hollingshead scale. 25 Psychiatric assessments of probands and relatives relied on the K-SADS-E 26, 27 for subjects aged under 18 years and the Structured Clinical Interview for DSM 28, 29 (supplemented with modules from the K-SADS-E to assess childhood diagnoses) for subjects aged 18 years and older. The interviewers had undergraduate degrees in psychology and were extensively trained and supervised. Based on 500 interviews the median kappa coefficient between a trained rater and an experienced clinician was 0.98. Kappa coefficients for individual diagnoses included ADHD (0.88), conduct disorder (1.0), major depression (1.0), mania (0.95), separation anxiety (1.0), agoraphobia (1.0), panic (0.95), and substance use disorder (1.0). We considered a diagnosis present if DSM diagnostic criteria were unequivocally met. A committee of board-certified child and adult psychiatrists who were blind to each subject's ADHD status, referral source, and all other data resolved diagnostic uncertainties. Diagnoses presented for review were considered positive only when the committee determined that diagnostic criteria were met to a clinically meaningful degree. We estimated the reliability of the diagnostic review process by computing kappa coefficients of agreement for clinician reviewers. For these diagnoses, the median reliability between assigned diagnoses by individual clinicians and the review committee was 0.87. Kappa coefficients for individual diagnoses included ADHD (1.0), conduct disorder (1.0), major depression (1.0), mania (0.78), separation anxiety (0.89), agoraphobia (0.80), panic (0.77), and substance use disorder (1.0). All assessment personnel were blind to proband diagnosis (ADHD or control) and ascertainment site (psychiatric or pediatric). To reflect the increased level of concern about ND in youth, we defined ND as daily smoking for more than 1 month for an age of onset before 18 years. For onset at age 18 years or after, ND was defined as daily smoking of at least 1 pack of cigarettes. ND was assessed in the girls' study at all assessments, but only assessed in the boys' study at the 4-and 10-year follow-ups. This difference was because the study of girls was started 5 years after the initiation of the study of boys, and we decided to formally assess smoking in both samples at the same time (baseline assessment for the girls' study and 4-year follow-up for the boys' study).
Statistical Analysis
Logistic regression was used to compare rates of ADHD and ND in first-degree relatives of probands with and without ADHD and ND. Only probands and relatives aged at least 12 years at their last assessment were used for this analysis. We controlled for demographic confounders (social class, proband age, and age of relative) in all models. To account for the nonindependence of family members, we used the Huber correction 30 to produce robust variances for all statistical tests. All tests used STATA 31 and were 2-tailed. Alpha was set at 0.05.
Results
Among 257 probands with ADHD, 37.7% (n = 97) met criteria for ND, compared with 17.9% (n = 41) of 229 control probands (OR = 1.8, 95% CI 1.2 to 2.6, z = 3.08, P = 0.002). For this familial risk analysis, probands were stratified by the presence or absence of ND. Thus we made comparisons between first-degree relatives of control probands without ND (control group: n = 614, from 188 families), relatives of control probands with ND (ND group: n = 139, from 41 families), relatives of ADHD probands without ND (ADHD group: n = 547, from 160 families), and relatives of ADHD probands with ND (ADHD + ND group: n = 327, from 97 families). We found no significant differences in the sex distributions of probands and relatives between the 4 proband groups (Table 1 ). However, the groups differed in family SES, with ADHD and ADHD + ND families having a lower SES than did control families. We also found significant differences for age at last assessment, with the ADHD probands and relatives being the youngest, followed by the control group, then the ADHD + ND group, and finally the ND probands and their relatives. Therefore, we controlled for social class, proband age, and age of relative in all subsequent analyses. As shown in Figure 1A , ADHD was significantly more prevalent in the relatives of probands with ADHD (25.0%) and those with ADHD + ND (27.4%), compared with the control group (8.9%; χ 2 = 38.19, df = 1, compared with ADHD group; χ 2 = 38.72, df = 1, compared with ADHD + ND group, both P < 0.001) and the ND group (9.6%; χ 2 = 10.74, df = 1, compared with ADHD group; χ 2 = 13.23, df = 1, compared with ADHD + ND group, both P < 0.001). The prevalence of ADHD did not differ between relatives of the 2 ADHD groups (ADHD group: 25.0%, compared with ADHD + ND group: 27.4%; χ 2 = 0.64, df = 1, P = 0.42). We found an increase in the prevalence of ND in the relatives of probands with ND (39.4%) and of those with ADHD + ND (48.8%), compared with the control group (27.7%; c 2 = 5.15, df = 1, P = 0.02, compared with ND group; c 2 = 19.49, df = 1, P < 0.001, compared with ADHD + ND group) ( Figure 1B) . The ADHD + ND group also showed a significantly higher prevalence of ND than did the ADHD group (48.8%, compared with 30.0%; c 2 = 15.36, df = 1, P < 0.001). Among relatives in the ADHD + ND group, we assessed the comorbidity of ADHD with ND ( Figure 1C ). Rates of ND did not vary significantly between relatives with and without ADHD (51.4%, compared with 45.4%; c 2 = 0.76, df = 1, P = 0.38). We also observed no evidence of assortative mating (that is, nicotine-dependent parents were not more likely to mate with parents with ADHD) in the ADHD + ND group (Fisher exact tests, P > 0.99 for mothers with ADHD and nicotine-dependent fathers, and P = 0.14 for fathers with ADHD and nicotine-dependent mothers).
Discussion
We conducted a systematic evaluation of the familial relationship between ADHD and ND using a wellcharacterized longitudinal sample of grown-up children of both sexes, with and without ADHD, and their first-degree relatives. We found the following:
1. ADHD in the proband significantly increased the risk for ADHD in relatives irrespective of ND status. 2. ND in probands significantly increased the risk for ND in relatives irrespective of ADHD status 3. No evidence of cosegregation or assortative mating between ADHD and ND appeared. These findings are most consistent with the hypothesis that ADHD and ND transmit independently in families and that the comorbidity between ADHD and ND is not due to genetic influences. Strengths of this study include its large sample size, the inclusion of probands who were ascertained from pediatric and psychiatric sources, the inclusion of equal numbers of probands of both sexes, the reliance on direct interviews of probands and first-degree relatives using structured diagnostic interviews, and that probands and relatives were adults and therefore had passed through the age of risk for nicotine addiction. The rate of ND in our study's control probands and their relatives (27.0%) is consistent with that reported in the US NCS (24%), 32 supporting the validity of our assessment methodology. Also consistent with the literature 5, 6 are our results showing a significantly higher risk for ND in subjects with ADHD than in control subjects. The 10-year follow-up of the NCS (that is, the NCS-2) found a similar increased risk for ND in respondents with ADHD (OR 1.8) 33 as that identified in our study. Our finding of independent transmission between ADHD and ND in families has several implications. Because the familial transmission of ND is equally strong in families with and without ADHD, we cannot attribute ND in the families of nicotine-dependent youth with ADHD to nonfamilial environmental factors. Independent transmission also means that, among relatives of nicotinedependent probands, ADHD and ND are not comorbid conditions ( Figure 1C ). This lack of comorbidity cannot be attributed to low statistical power as we included 327 subjects in the relevant analysis. Finding comorbidity in probands but not in relatives could be due to Berkson's bias, namely, that people with 2 disorders are more likely to be referred than those with 1 disorder. But Berkson's bias cannot explain the significant comorbidity between ADHD and ND reported in epidemiologic studies. 6, 33 Thus it is possible that risk factors for the comorbidity between ADHD and ND differ in familial and community samples.
Like other children with nicotine-dependent parents, children with ADHD who have nicotine-dependent parents represent a subgroup at higher risk for the development of ND. These insights offer new opportunities for specifically targeting these high-risk children with ADHD for early identification and preventive efforts aimed at reducing their risk for ND. This issue of early identification of children at high risk for ND is of particular clinical and public health importance considering the high prevalence of ADHD, the increased risk for smoking in this population, and the enormous morbidity and mortality associated with smoking. Any reduction in the risk for smoking translates into reduced morbidity and mortality. For example, youth who smoke increase their mortality risk by 5 to 10 years, 34 and reductions in smoking rates can improve projected life expectancy and quality adjusted life expectancy by similar amounts. 35 Our results need to be interpreted in light of some limitations. Although probands and their siblings were assessed at baseline and follow-up assessments, parents were assessed only at baseline. It is possible that additional cases of nicotine addiction could have emerged in the parents during the 10-year follow-up period. We only measured smoking and not other forms of tobacco use. Although our follow-up assessments were based on DSM-IV, our sample was originally ascertained with DSM-III-R criteria, so findings may have differed had No ADHD ADHD DSM-IV been used initially. However, Biederman et al 36 previously showed that 93% of children with a DSM-III-R diagnosis of ADHD also received a similar DSM-IV diagnosis. Finally, as the sample population was referred and overwhelmingly Caucasian, more work is needed to evaluate whether these results can be generalized to community samples and other racial or ethnic groups.
Conclusions
In a sample of pediatrically and psychiatrically referred children and adolescents with ADHD of both sexes followed longitudinally into young adult years, familial risk analyses suggest that the association between ADHD and ND is most consistent with the hypothesis of independent transmission. These findings offer opportunities for the early identification of a subgroup of children with ADHD at high risk for developing ND based on parental history of smoking.
